Health
Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten disease – News-Medical.Net
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.
Reviewed by Emily Henderson, B.Sc.Aug 10 2020
Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease. Adeno-associated viral (AAV)-mediated expression of the human CLN3 gene led to significant survival of bipolar cells and pre-served retinal function, as reported in the peer-reviewed journal Human Gene Therapy.
Batten disease is a group of fatal, inherited lysosomal storage disorders that predominantly affect children. The m…
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
General20 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business23 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock